IL6 and Hyperglycemia: Advanced glycation end products (AGEs), the pathological product of hyperglycemia, can promote M1 activation of mouse primary Mφs and increase the expression of nitric oxide synthase (NOS)2, TNF-α, and IL-6 based on the upregulation of the RAGE/NF-κB pathway (85).